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Abstract
Background: For many years there has been a debate as to which is the method of choice in treating patients
with esophageal perforation. The literature consists mainly of small case series. Strategies for aiding patients struck
with this disease is changing as new and less traumatic treatment options are developing. We studied a relatively
large consecutive material of esophageal perforations in an effort to evaluate prognostic factors, diagnostic efforts
and treatment strategy in these patients.
Methods: 125 consecutive patients treated at the University Hospital of Lund from 1970 to 2006 were studied
retrospectively. Prognostic factors were evaluated using the Cox proportional hazards model.
Results: Pre-operative ASA score was the only factor that significantly influenced outcome. Neck incision for
cervical perforation (n = 8) and treatment with a covered stent with or without open drainage for a thoracic
perforation (n = 6) had the lowest mortality. Esophageal resection (n = 8) had the highest mortality. A CAT scan or
an oesophageal X-ray with oral contrast were the most efficient diagnostic tools. The preferred treatment strategy
changed over the course of the study period, from a more aggressive surgical approach towards using covered
stents to seal the perforation.
Conclusion: Pre-operative ASA score was the only factor that significantly influenced outcome in this study.
Treatment strategies are changing as less traumatic options have become available. Sealing an esophageal
perforation with a covered stent, in combination with open or closed drainage when necessary, is a promising
treatment strategy.
Background
A perforation of the oesophagus implies a serious thera-
peutic problem. If a mediastinitis develops the situation
can become life threatening in a few hours. Strategies
for aiding patients struck with this disease are changing
as new and less traumatic treatment options are devel-
oping. The introduction of covered metallic esophageal
stents (SEMS) has offered a less traumatic alternative. In
this situation, when new methods are evaluated, it is
important to have knowledge about how these patients
have been treated in the past.
Treatment of esophageal perforations remains contro-
versial and no consensus has been reached on the best
treatment option. This is a reflection of the fact that
this condition is difficult to study with a high degree of
scientific power. The incidence of esophageal perfora-
tion is low and limited clinical materials are still
reported. In 1997 when Brauer and co-workers pub-
lished a review based on all publications on post-emetic
spontaneous rupture of the oesophagus, more than 80%
consisted of materials with fewer than ten cases [1].
A tt h eU n i v e r s i t yH o s p i t a lo fL u n dp a t i e n t sw i t he s o -
phageal perforation requiring surgery have been treated
either at the department of general surgery or of thor-
acic surgery. This study presents the collected experi-
ence from both departments over a 36-year period. Even
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perforation, the extent of surgical treatment has varied
over time. The aim of this study was to study how treat-
ment strategies have changed over time at our hospital,
to compare outcome in response to the treatment of
choice, and to evaluate diagnostic efforts. Further, we
wanted to try to identify prognostic factors that might
have influenced outcome.
Methods
During the period September 1970 to September 2006,
128 patients were treated at the University Hospital of
Lund with a diagnosis of esophageal perforation. From
1970 to 1987 the patients were collected prospectively
(n = 71). From 1988 to 2006 the patients were identified
by searching both the local hospital register as well as
the national hospital discharge register (National Board
of Health and Welfare) (n = 57). Three records in the
prospectively collected group could not be found and
these patients were excluded. We studied the records of
the remaining 125 patients and the following variables
were recorded: age, sex, length of hospital stay, co-exist-
ing diseases, time from start of symptoms to treatment,
site and cause of perforation, diagnostic modality,
method of operation, complications and mortality. The
American Society of Anaesthesiologists (ASA) score (1,
healthy patients, no medical problems, 2 mild systematic
disease, 3 severe systematic disease, but not incapacitat-
ing, 4 severe systematic disease that is a constant threat
to life, 5 moribund, not expected to live 24 hours irre-
spective of operation) estimated by the anaesthesiologist
was also recorded.
For esophageal stenting a covered Ultraflex® stent
(Boston Scientific) was used.
Statistical methods
Data was expressed as median values, with minimum and
maximum as range. The Chi-square test or Fisher’s exact
test was used to compare categorical data. Differences
between two continuously distributed groups of patients
were analyzed with the Mann-Whitney U-test or for
more than two groups with the Kruskall-Wallis test. Sur-
vival rates were graphically depicted by Kaplan-Meier
plots, and comparisons were made using a Cox propor-
tional hazard model. We initially evaluated the following
factors for potential impact on survival: age (continuous
and categorical), decade of surgery (categorical), surgical
procedure (categorical), pharyngostoma or not (categori-
cal), site of perforation (cervical, thoracic upper, middle,
lower as categorical), type of perforation (spontaneous or
iatrogenic as categorical), thoracotomy or not (categori-
cal), suturing of the perforation or not (categorical), time
elapsed between perforation and surgery (continuous),
co-morbidity (categorical), sex (categorical), ASA-score
(categorical). In order to find the best model for the
determination of survival a stepwise backward Wald pro-
cedure was used to eliminate non-significant impact fac-
tors. All reported p-values were two-sided, and p-values
below 0.05 were considered to indicate statistical signifi-
cance. Statistical analyses were performed with SPSS ver-
sion 12 (SPSS, Chicago, Illinois).
The ethical committee of Lund University hospital
approved the study.
Results
The median number of patients treated for esophageal
perforation, requiring any form of surgical intervention,
annually was 3 (0-8). When comparing consecutive five-
year periods a maximum of 4.8 patients was treated
yearly; this occurred during the period 1976 to 1980
(Figure1).
Basic data regarding the 125 patients are presented in
Table 1. The male to female ratio was 62:38. The differ-
ence in sex ratio was significant comparing iatrogenic-
and spontaneous perforations (p = 0.002) and regarding
site of perforation i.e. cervical-compared to thoracic per-
forations (p = 0.009).
The cause of perforation was iatrogenic in 70 cases
and spontaneous in 49. Of the remaining cases the
aetiology was foreign bodies (fish bones) in three while
in three cases the cause was unknown (Table 2).
For iatrogenic perforations the hospital stay was signif-
icantly shorter than for spontaneous perforations, 16(2-
87 days compared to 35(4-132) days (p = 0.009). We
were unable to collect data concerning hospital stay and
hospital mortality for one patient in each group.
The ASA patient status score was missing in 23 cases.
Of these 23 patients one had a cervical perforation
while 22 had thoracic perforations. With regard to
aetiology, 10 perforations were iatrogenic, 11 were spon-
taneous, while two were caused by foreign material.
For the different time periods the missing ASA data
were: 1970-79 seven, 1980-89 four, 1990-99 four and
2000-06 eight.
Table 2 shows the material divided into the time peri-
ods 1970 to 1979, 1980 to 1989, 1990 to 1999 and 2000
to 2006. There was a significant difference between the
groups with regard to the distribution of iatrogenic and
spontaneous perforations (p = 0.009).
A chest X-ray was performed on 44 patients (35%)
and gave a suspicion of the diagnosis in 86%. Plain chest
X-ray was considered “true positive” i ft h e r ew e r ef i n d -
ings that provided suggestive support for esophageal
perforation, for example presence of mediastinal gas.
The initial plain chest X-ray was complemented by con-
trast X-ray of the oesophagus or CAT-scan in most of
the cases. Ninety-eight patients (78%) had a contrast X-
ray of the oesophagus, which was true positive (93%).
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trast was 95% (Table 3).
Only eight percent of the patients had major surgery
in the meaning of resection with primary reconstruction
or exclusion. The majority of patients were operated
upon with different kinds of drainage procedures as pre-
sented in Tables 4 and 5. Two patients are not pre-
s e n t e di nt h et a b l e s .O n ed i e db e f o r eat r e a t m e n t
decision had been made. One patient was operated
trough an abdominal incision.
There were three patients in the group “only drainage”
who received a covered stent. Among these patients
there was one re-operation but no mortality.
In figure 2 the numbers of patients treated according
to each of the eight different treatment strategies (see
Table 4 and 5) for each decade are presented.
In the group of patients who received intervention less
than 24 hours after onset of symptoms 16 out of 71 died
(22%). In the group of patients who were treated after
24 hours from onset of symptoms nine out of 48 died
(19%).
When all potential impact factors for survival were
compared and adjusted for in a multivariable Cox analy-
sis, the only significant impact factor for survival was
the ASA scores (p = 0.017).
Discussion
Treatment strategies
In this series we have identified eight different methods
of treatment for esophageal perforations at the Lund
University hospital from 1970 to 2006 (tables 4-5). The
placement of a self-expandable covered metallic stent
(SEMS) to cover the thoracic perforation, in combina-
tion with drainage if necessary, was associated with the
lowest mortality in this study. It is, however, difficult to
draw any firm conclusions regarding the effectiveness of
this treatment modality since only eight patients
received this treatment. The fact that mortality in eight
patients after primary resection was 50% provides sug-
gestive support for the notion that a minimally invasive
procedure might be a better option after all. An interest-
ing option in tumour perforations is to use a SEMS as a
Figure 1 Number of esophageal perforations at Lund
University Hospital per five years.
Table 1 Data on patients treated for an esophageal perforation from 1970-2006 at Lund University hospital
Total n = 125 Cervical n = 15 Thoracic n = 110 Iatrogenic n = 70 Spontaneous n = 49
Sex
male 77 (62%) 6 (40%) 71 (64%)
2 36 (51%) 39 (80%)
1
female 48 (38%) 9 (60%) 39 (35%) 34 (49%) 10 (20%)
Age (yrs)
median (min-max) 65 (4-92) 67 yrs 64 yrs 65 yrs 61 yrs
ASA classification Pre-operatively
mean 2,7 2,5 2,8 2,6 3,0
Mortality
hospital 24 (19%) 1 (7%) 23 (21%) 14 (20%) 10 (20%)
<90 days post op 23 (18%) 1 (7%) 22 (20%) 14 (20%) 9 (18%)
Days in Hospital
median (min-max) 21 (2-132) 16 (9-74) 22 (2-132) 16 (2-87) 35 (4-132)
3
Cervical perforations 11 (16%) 0
Thoracic perforations x x x 59 (84%) 49 (100%)
Concurrent diseases:
Significant co-morbidity 36 (29%) 3 (20%) 33 (30%) 22 (31%) 13 (26%)
Benign esophageal disease 66 (53%) 5 (30%) 61 (55%) 48 (69%) 17 (35%)
Malignant esophageal disease 12 (10%) 0 12 (11%) 9 (13%) 3 (6%)
ASA score ranges from 1 (healthy) to 5 (moribund).
In three patients cause of perforation was foreign material and in three unknown.
1 p = 0,002
2 p=0 , 0 0 9
3 p = 0,001
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acute setting.
The construction of a pharyngostoma for diversion of
saliva was frequently used at our hospital during the
70’s, 80’sa n d9 0 ’s as a safety precaution in combination
with a suture of the perforation. A pharyngostoma, how-
ever, is very uncomfortable for the patient, and a second
surgical procedure will be necessary to restore continu-
ity. Since our results indicate that pharyngostoma after
esophageal perforation is associated with longer hospital
stay, and importantly, had no beneficial effects on mor-
tality, we conclude that pharyngostomy should be used
with restraint.
The treatment strategy for esophageal perforation in
our hospital has changed markedly during the last dec-
ade (Figure 2). In the 70’s, 80’sa n d9 0 ’sa ne x t e n s i v e
surgical approach was used and approximately 25% of
the patients received a pharyngostomy for diversion.
S i n c e2 0 0 0o n l yo n eo u to f2 5p a t i e n t s( 4 % )w e r eo p e r -
ated upon in this manner and the most common opera-
tion today is sealing of the perforation endoscopically
using a SEMS in combination with open or closed
drainage when necessary. During the period 2000 to
2006, 52% of the patients were treated with open drai-
n a g ew i t h o u ts i m p l es u t u r ea n d / o raS E M S .A ss e e ni n
table 2, both mortality and hospital stay are lower dur-
ing this period than in previous periods, indicating that
the change in treatment strategy may have improved
outcome, although other factors, for example improved
intensive care, may have contributed. One of the largest
consecutive series published regarding SEMS treatment
of esophageal perforations comes from Johnsson and
co-workers in Gothenburg [2]. In this series all thoracic
esophageal perforations from 1998 to 2004 (n = 22) was
treated with a SEMS and favourable results are reported.
However, there are reports that cases of thoracic per-
forations without sepsis, can be treated conservatively
with good results [3-5]. Primary repair with or without
reinforcement is probably standard treatment for a per-
foration of the thoracic oesophagus at most centres.
Some authors have advocated that primary repair should
only be used in patients with early perforations and
recommend resection or diversion when the perforation
is older than 24 hours [6-8]. This has however been
challenged by several groups that report good results
with this technique even in patients who come to sur-
gery late [9-13]. In cases of malignant disease in the
oesophagus a resection should be performed [14-16]. In
cases with severe damage to the oesophagus and severe
contamination, an esophageal resection, diversion, exclu-
sion or T-tube operation can be considered [6,7,17,18].
There are very little hard evidence published regarding
the treatment of esophageal p e r f o r a t i o n s ,t h i si sad i s -
ease that is difficult to study because of its low inci-
dence and acute nature. We believe that this study
Table 2 Data on patients treated for an esophageal perforation from 1970-2006 at Lund University hospital
1970-79 n = 36 1980-89 n = 37 1990-99 n = 27 2000-06 n = 25
Sex,
male 17 (47%) 25 (68%) 21 (78%) 14 (56%)
female 19 (53%) 12 (32%) 6 (22%) 11 (44%)
Age
median (min-max) 66 (15-90) 67 (4-83) 61 (44-88) 64 (24-92)
ASA classification pre-operatively (mean) 2,5 2,9 2,8 2,6
Mortality <90 days post op 10 (28%) 6 (16%) 5 (18%) 2 (8%)
Days in hospital
median (min-max) 24 (5-87) 29 (5-132) 21 (3-67) 18 (2-101)
Iatrogenic perforations 26 (72%) 14 (38%) 14 (52%) 16 (64%)
1
Spontaneous perforations 8 (22%) 22 (59%) 12 (44%) 7 (28%)
Concurrent diseases:
Significant co-morbidity 7 (19%) 15 (40%) 6 (22%) 8 (32%)
Benign esophageal disease 20 (56%) 14 (38%) 17 (63%) 15 (60%)
Malignant esophageal disease 2 (6%) 3 (8%) 3 (11%) 4 (16%)
ASA score ranges from 1 (healthy) to 5 (moribund)
1 p = 0,009
Table 3 Methods used to diagnose an esophageal
perforation
Diagnostic
tools
n:o of cases used
n (%)
True positive
n (%)
False negative
n (%)
CAT-scan 22 (18) 21 (95) 1 (5)
Contrast plain
film
98 (78) 91 (93) 7 (7)
Plain chest X-
ray
44 (35) 38 (86) 6 (14)
Gastroscopy 5 (4) 4 (80) 1 (20)
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including pharyngostoma, which was performed at our
unit in the 70’s, 80’sa n d9 0 ’ss h o u l db eu s e dm o r e
moderately.
The acute surgical treatment of this condition includes
two major aspects, sealing the perforation and drainage.
This can be accomplished with conventional surgical
intervention but often endoscopic methods, in combina-
tion with interventional radiology, are sufficient. It is
important to understand the heterogeneity in this group
of patients. In a patient with an iatrogenic perforation
that is diagnosed immediately a SEMS in combination
with a thoracic drainage tube is likely to be sufficient if
the perforation is not too large. In spontaneous perfora-
tions of the distal oesophagus with severe contamination
of the pleural cavity, surgery is often a better option in
order to remove debris and because SEMS sometimes
do not provide sufficient sealing in this area when its
distal part dip into the stomach. In cervical perforations
with no sign of mediastinal contamination drainage
alone is the method of choice initially. Localization, size,
degree of contamination, elapsed time since perforation
and the patients general condition are all parameters
that needs to be considered before a treatment decision
is made.
Diagnostic tools
One aim of the present study was to examine the effec-
tiveness of different diagnostic tools. According to our
data, reaching a diagnosis is rarely a problem if the sus-
picion of an esophageal perforation is raised. In our ser-
ies, a CAT scan or an investigation with contrast X-ray
of the oesophagus had the best sensitivity and specificity
(Table 3). However, even a simple chest X-ray often
contributed to the diagnosis. Considering the advances
of the CAT-scan during recent years, this method in
combination with contrast in the oesophagus should be
the method of choice when an esophageal perforation is
Table 4 Treatment strategies in esophageal perforations
Number in figure 2 12 3 4 5
Thoracotomiced
patients
All + Pharyngostoma+simple
suture
+
Pharyngostoma
+ Simple
suture
Only Drainage
(+/- stent)
Esophageal resection
or exclusion
n (%) 99 (79) 13 (10) 20 (16) 34 (27) 24 (24) 8 (8)
Pre-operative ASA
score
mean 2,8 3,0 2,8 2,7 2,7 2,4
Post-operative
complications
47 (47) 10 (77) 9 (45) 16 (47) 9 (38) 4 (50)
Re-operations 12 (12) 2 (15) 3(15) 3 (9) 3 (12) 1 (12)
Days in hospital
median (min-max) 25 (3-132) 45 (16-67) 36 (5-132) 21 (5-70) 21 (3-102) 22 (4-87)
Hospital mortality 20 (20) 2 (15) 4 (20) 7 (21) 3 (12) 4 (50)
Mortality < 90 days
post op
19 (19) 2 (15) 3 (15) 7 (21) 3 (12) 4 (50)
There were 3 patients in the group “only drainage” who received a covered stent. Among these patients there was one re-operation but no mortality.
ASA score ranges from 1 (healthy) to 5 (moribund).
Table 5 Treatment strategies in esophageal perforations
Number i figure 2 67 8
Not thoracotomiced patients All Neck incision Covered stent Only conservative
n (%) 26 (21)
1’
2 8 (6) 6 (5) 10 (8)
Pre-operative ASA Score
mean 2,6 2,4 2,8 2,8
Complications 7 (23)
2 1 (12) 2 (33) 3 (30)
Late thoracotomy 4 (15)
2 0 2 (33) 1 (10)
Days in hospital median (min-max) 16 (2-126) 15 (9-32) 14 (12-17) 18 (5-126)
Hospital mortality 4 (15)
1 0 0 3 (30)
Mortality < 90 days post op 4 (15)
1 0 0 3(30)
1 One patient died before treatment decision (diagnoses at autopsy).
2 One patient was operated upon through an abdominal incision. This patient survived but had to be re-operated upon.
ASA score ranges from 1 (healthy) to 5 (moribund)
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detect and estimate the size of the defect. A large
amount of contrast medium in the pleural cavity indi-
cates a large perforation with heavy contamination. At
our centre we frequently perform an endoscopy as a
complement before the final treatment decision in order
better evaluate the size and location of the perforation.
Prognostic factors
Pre-operative ASA score was the only factor that signifi-
cantly influenced outcome in the Cox proportional
hazards model. Age had a major influence though its
effect did not reach the level of statistical significance.
To our surprise, cause of perforation and time interval
from symptom to treatment did not significantly influ-
ence outcome in this study, even though others also has
reported this lack of correlation [8,11,19]. Spontaneous
perforations did however have a longer hospital stay
compared to iatrogenic perforations. In a review by
Brinster et al [14] results from nine recent case series
with a total of 431 patients, were studied. They found a
higher mortality among patients with a spontaneous
perforation (36%) compared to an iatrogenic perforation
(19%). They also found an influence of the time factor
on mortality in 390 patients from 11 series. If treatment
was delayed more than 24 hours, mortality in these ser-
ies was 27% compared to 14% if treatment was initiated
within 24 hours. Even higher mortality figures with
d e l a y e dt r e a t m e n tw a sr e p o r t e db yB r a u e re ta lf r o ma
large literature review of Boerhaaves syndrome [1]. This
is consistent with results from studies regarding gastric
or duodenal perforations [20]. Although our study did
not confirm the importance of these prognostic factors
it is likely that they have some influence on outcome,
particularly the time to treatment factor. According to
our data, and not surprisingly, the general condition of
the patient at the time of diagnosis is probably the most
important prognostic factor. This is a heterogeneous
material with all sorts of esophageal perforations. In the
case of a small, contained perforation that does not
rapidly cause mediastinitis, the diagnosis might be con-
siderably delayed without a septic condition developing.
On the other hand, a patient who does develop sepsis
because of mediastinal and pleural contamination will
be in poor condition even if treatment is prompt. This
is supported by the results obtained in a previous multi-
variate analysis from the Netherlands [19]. In that study
neither cause of perforation nor time interval signifi-
cantly influenced survival. However, they report a
marked difference in mortality if a perforation was con-
fined to the mediastinum or if it had perforated the
pleura. It would have been interesting to stratify our
patients, other than ASA classification, according to the
seriousness of the perforation. This was however diffi-
cult due to the retrospective design of this study.
Not surprisingly, cervical perforations had a lower
mortality compared to perforations in the thoracic cav-
ity. This is consistent with earlier reports [19,21-24].
The reason for the more benign course in proximal per-
forations is that mediastinitis often does not occur;
infected material spreads slowly from the neck, through
the retro-esophageal space, to the mediastinum. These
patients can often safely be approached conservatively.
Limitations of the study
This is a retrospective study with a long observation
time span. Because many parameters have changed dur-
ing this period, for example the quality of intensive care,
it is very difficult to compare outcome between the dif-
ferent time cohorts. Another limitation is the fact that
the material is heterogeneous. We believe, however that
the material is too small to enable further stratification.
Conclusions
Pre-operative ASA score was the only factor that signifi-
cantly influenced outcome in this study. Sealing an eso-
phageal perforation with a covered stent, in combination
with open or closed drainage depending on the patient’s
condition, is a promising treatment strategy that we
believe can be the future method of choice for treatment
of this condition.
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